Predicting sustained ventricular arrhythmias in dilated cardiomyopathy: a meta‐analysis and systematic review
Open Access
- 14 April 2020
- journal article
- review article
- Published by Wiley in ESC Heart Failure
- Vol. 7 (4), 1430-1441
- https://doi.org/10.1002/ehf2.12689
Abstract
Aims Patients with non‐ischaemic dilated cardiomyopathy (DCM) are at increased risk of sudden cardiac death. Identification of patients that may benefit from implantable cardioverter‐defibrillator implantation remains challenging. In this study, we aimed to determine predictors of sustained ventricular arrhythmias in patients with DCM. Methods and results We searched MEDLINE/Embase for studies describing predictors of sustained ventricular arrhythmias in patients with DCM. Quality and bias were assessed using the Quality in Prognostic Studies tool, articles with high risk of bias in ≥2 areas were excluded. Unadjusted hazard ratios (HRs) of uniformly defined predictors were pooled, while all other predictors were evaluated in a systematic review. We included 55 studies (11 451 patients and 3.7 ± 2.3 years follow‐up). Crude annual event rate was 4.5%. Younger age [HR 0.82; 95% CI (0.74–1.00)], hypertension [HR 1.95; 95% CI (1.26–3.00)], prior sustained ventricular arrhythmia [HR 4.15; 95% CI (1.32–13.02)], left ventricular ejection fraction on ultrasound [HR 1.45; 95% CI (1.19–1.78)], left ventricular dilatation (HR 1.10), and presence of late gadolinium enhancement [HR 5.55; 95% CI (4.02–7.67)] were associated with arrhythmic outcome in pooled analyses. Prior non‐sustained ventricular arrhythmia and several genotypes [mutations in Phospholamban (PLN), Lamin A/C (LMNA), and Filamin‐C (FLNC)] were associated with arrhythmic outcome in non‐pooled analyses. Quality of evidence was moderate, and heterogeneity among studies was moderate to high. Conclusions In patients with DCM, the annual event rate of sustained ventricular arrhythmias is approximately 4.5%. This risk is considerably higher in younger patients with hypertension, prior (non‐)sustained ventricular arrhythmia, decreased left ventricular ejection fraction, left ventricular dilatation, late gadolinium enhancement, and genetic mutations (PLN, LMNA, and FLNC). These results may help determine appropriate candidates for implantable cardioverter‐defibrillator implantation.Keywords
Funding Information
- UCLH Biomedical Research Centre
- Deutsches Zentrum für Herz-Kreislaufforschung (81X3500117)
This publication has 39 references indexed in Scilit:
- Sudden Cardiac Death Risk Stratification in Patients With Nonischemic Dilated CardiomyopathyJournal of the American College of Cardiology, 2014
- A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)European Heart Journal, 2013
- Assessing Bias in Studies of Prognostic FactorsAnnals of Internal Medicine, 2013
- Aging-Associated Cardiovascular Changes and Their Relationship to Heart FailureHeart Failure Clinics, 2012
- Stereotactic radiosurgery for glioblastoma: retrospective analysisRadiation Oncology, 2009
- Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part II: Electrocardiography Diagnostic Statement List A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized ElectrocardiologyJournal of the American College of Cardiology, 2007
- Recommendations for the Standardization and Interpretation of the ElectrocardiogramCirculation, 2007
- Mutation in sodium–calcium exchanger 1 (NCX1) causes cardiac fibrillation in zebrafishProceedings of the National Academy of Sciences of the United States of America, 2005
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureThe New England Journal of Medicine, 2004
- Gender differences in arrhythmiasClinical Cardiology, 2002